It would be up to the tga.
To have a punt, I suspect it will be schedule 2 meaning it can only be sold in pharmacies with limited advice/red tape required. Most other nasal sprays are schedule 2.
unless it's considered extremely safe which is possible I doubt it would start in supermarkets. they could always start at schedule 2 or 3 and down schedule as time and evidence extends where it might land itself on the supermarket shelves.
they might have caution advice like maximum number of sprays in a day to satisfy toxicology based on limited clinical studies from the nasal spray. hopefully fleurstat has generated significant safety data in its post market surveylance which may assist in the safety profile as it's the same active ingredient.
bit all over the place but just my thoughts.
It would be up to the tga. To have a punt, I suspect it will be...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |